US EditionPublished • loading... • Updated
Arm-to-Disarm: Re-engineering a TB Drug to Kill Persisters - BioPatrika
Summary by biopatrika.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Arm-to-Disarm: Re-engineering a TB Drug to Kill Persisters - BioPatrika
Re-engineering a TB Drug to Eliminate Dormant Persister Bacteria Research Summary: We chemically modified moxifloxacin into a smart, enzyme-activated prodrug that easily enters bacteria and selectively kills dormant TB persisters, offering a blueprint to shorten therapy and reduce relapse. Author interview T. Anand Kumar earned his PhD from IISER Pune and is currently a postdoctoral […] The post Arm-to-Disarm: Re-engineering a TB Drug to Kill Pe…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
